Please join us for a lively discussion with healthcare investors on how they are assessing risk in an extremely competitive and somewhat wild market. Ari Markenson, a partner in our healthcare and corporate practices, will be moderating this virtual discussion, which will cover such questions as the following:
- Have diligence processes changed because of market conditions?
- Has the pandemic affected risk analysis?
- Have types of diligence/risk analysis changed?
- Are there specific sectors of the industry that require differing types of analysis?
Ari Markenson, Partner, Venable LLP
Pete Tedesco, Managing Partner, Health Enterprise Partners
Michael Vaupen, Managing Director, Vestar Capital Partners
Nick Coleman, Vice President, Excellere Partners